Five Pew-Stewart scholars chosen to advance cutting-edge cancer research
(Pew Charitable Trusts) The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced today the 2021 class of the Pew-Stewart Scholars Program for Cancer Research. The five early-career scholars who comprise the 2021 class will each receive a four-year grant to advance cutting-edge research into the development, diagnosis, and treatment of cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2021 Category: Cancer & Oncology Source Type: news
Liver cancer call for help
(Flinders University) Rising numbers of liver cancer in Aboriginal and Torres Strait Islander communities has led experts at Flinders University to call for more programs, including mobile liver clinics and ultrasound in rural and remote Australia. The Australian study just published in international Lancet journal EClinicalMedicine reveals the survival difference was largely accounted for by factors other than Indigenous status - including rurality, comorbidity burden and lack of curative therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2021 Category: Cancer & Oncology Source Type: news
Cancer cells fight for their footing by using an ageing gene
(University of Helsinki) New results allow the development of novel therapies for hereditary forms of intestinal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2021 Category: Cancer & Oncology Source Type: news
CNIO researchers discover that a protein that facilitates DNA repair may potentiate chemotherapy
(Centro Nacional de Investigaciones Oncol รณ gicas (CNIO)) CNIO researchers have found out how PrimPol protein helps the cell to survive the damage caused by chemotherapy and plan to use this knowledge to enhance cancer treatments. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2021 Category: Cancer & Oncology Source Type: news
Yale Cancer Center study reveals new pathway for brain tumor therapy
(Yale University) In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody. The study was published today online in the Journal of Clinical Investigation Insight. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2021 Category: Cancer & Oncology Source Type: news
Model suggests surgery should precede chemotherapy for select patients with ovarian cancer
(NYU Langone Health / NYU Grossman School of Medicine) Certain patients with an aggressive form of ovarian cancer have a better chance of a cure through surgical removal of their tumor before chemotherapy instead of the reverse, a new study shows. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news
Novel radiopharmaceutical tracks 'master switch' protein responsible for cancer growth
This study was presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news
Steven M. Larson, M.D., receives SNMMI 2021 Paul C. Aebersold Award
(Society of Nuclear Medicine and Molecular Imaging) Steven M. Larson, M.D., has been named the 2021 recipient of the prestigious Paul C. Aebersold Award. The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2021 Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news
Women leaving jail have high vaccine hesitancy; app drops resistance, boosts literacy
(University of Kansas) Researchers at the University of Kansas found high vaccine hesitancy among women leaving incarceration, a substantial and vulnerable population in the United States. However, a web-based health app proved effective at boosting the group's health literacy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news
Toward the first drug to treat a rare, lethal liver cancer
(Rockefeller University) After scouring more than 5,000 compounds, scientists have identified several new classes of therapeutics that may help treat fibrolamellar carcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news
New health benefits of red seaweeds unveiled
(Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign) Red seaweeds have been prevalent in the diets of Asian communities for thousands of years. In a new study, published in Marine Drugs, researchers have shown how these algae confer health benefits. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news
Targeted drug found effective in thwarting pancreatic tumors
(Virginia Commonwealth University) Through a pre-clinical study conducted in his former role at Moffitt Cancer Center and published in Clinical Cancer Research, Said Sebti, Ph.D., associate director for basic research at VCU Massey Cancer Center, identified a novel drug that effectively thwarts pancreatic tumors that are addicted to the cancer-causing mutant KRAS gene. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news
Black and white women have same mutations linked to breast cancer risk
(University of Pennsylvania School of Medicine) The prevalence of genetic mutations associated with breast cancer in black and white women is the same. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2021 Category: Cancer & Oncology Source Type: news
HPV vaccine has a significant impact even if all girls and boys are not vaccinated
(Tampere University) Human papillomavirus (HPV) vaccines applied in national vaccination programs protect against most cancers associated with oncogenic, high-risk (hr) HPV types. Two recent studies demonstrate the impact of gender-neutral HPV vaccination in the overall protection against hrHPV infections already with low vaccination coverage. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2021 Category: Cancer & Oncology Source Type: news
Financial toxicity impacts nearly 50% of women with gynecologic cancer
(Beth Israel Deaconess Medical Center) Researchers report on how a diverse cohort of gynecologic cancer patients are affected by financial distress, also called " financial toxicity " in acknowledgment of the health hazards it can pose, in the International Journal of Gynecological Cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2021 Category: Cancer & Oncology Source Type: news
